Symbols

NUVA(Delisted)

Nuvasive·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About NUVA

Nuvasive, Inc.

The leader in spine technology innovation

Industry

Established Date

07/21/1997

Listing Date

05/13/2004

Exchange

NASDAQ Stock Exchange

Full-time Employees

3,000

Fiscal Year Ends

12-31

Website

www.nuvasive.com

Security Type

Common stock

Office address

12101 Airport Way, Broomfield, Colorado, 80021

Business

Introduction

Nuvasive, Inc., was established in Delaware on July 21, 1997. Nuvasso Devices is a medical device company specializing in the development of minimally invasive spinal repair surgical products and procedures. The company's current product line is mainly focused on the application in minimally invasive spine surgery. The company's main products include minimally invasive surgery platforms and the provision of biological agents, cervical spine, motion protection products and intraoperative monitoring (IOM) services. The company's recently acquired subsidiary became Pulse Monitoring Company (Pulse Monitoring), which provides intraoperative monitoring (IOM) services in the observation of the spinal nervous system and other surgeries. The company will continue to focus on expanding the major research and development of its MAS product platform and advancing the application of its unique technology in the field of comprehensive surgery. The company invests a lot of its unique technical and product resources in training spine surgeons. The company will continue to train surgeons who are unfamiliar with the MAS product platform and surgeons who have previously participated in the MAS advanced product platform training program.

Company Financials

EPS

NUVA has released its 2023 Q2 earnings. EPS was reported at 0.56, versus the expected 0.56, meeting expectations. The chart below visualizes how NUVA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NUVA has released its 2023 Q2 earnings report, with revenue of 317.79M, reflecting a YoY change of 2.36%, and net profit of 7.36M, showing a YoY change of 924.64%. The Sankey diagram below clearly presents NUVA's revenue sources and cost distribution.